Guidant Up; J&J, AMD Fall Before Bell
607732
Shares of cardiovascular device maker  Guidant Corp. GDT.N jumped 6 percent on Tuesday, following a  report that Johnson & Johnson JNJ.N is in advanced talks to  buy it for more than $24 billion.
336391
U.S. blue chips closed slightly higher  on Thursday, helped by Johnson & Johnson Inc.'s JNJ.N $25  billion deal to buy Guidant Corp. GDT.N, but the broader  market fell, with Goldman Sachs Group Inc. GS.N dragging the  S&P 500 lower after posting quarterly revenues that  disappointed Wall Street.
420803
Johnson &amp; Johnson has agreed to buy Guidant Corp. for $25.4 billion in cash and stock, the companies said on Wednesday, giving the healthcare products maker a foothold
570897
Shares of Merck & Co. MRK.N fell  about 3 percent before the bell on Tuesday after the drug maker  said federal authorities are investigating circumstances  surrounding its withdrawal of pain-relief medicine Vioxx.
290458
Shares of medical device maker Guidant  Corp. GDT.N jumped on Tuesday after a report saying the  company was in advanced talks to be acquired by health products  maker Johnson & Johnson JNJ.N for more than $24 billion.
199086
Johnson & Johnson has agreed to  buy Guidant Corp. for $25.4 billion in cash and stock, the  companies said on Wednesday, giving the healthcare products  maker a foothold in the fast-growing market for implantable  devices that regulate heartbeats.
173356
Johnson & Johnson will buy Guidant  Corp. for $23.9 billion in cash and stock, giving the  health-care products maker a foothold in the fast-growing  market for implantable devices that regulate heartbeats, J&J  said on Wednesday.
336179
LONDON: Johnson &amp; Johnson has agreed to acquire Guidant Corp for US$25.4bil, adding electrical devices for treating heart disease to a line-up of thousands of health products ranging from Band-Aids to cardiac stents.
282709
Eight months after Boston Scientific Corp. won a bidding war for heart-device maker Guidant Corp. , loser Johnson &amp; Johnson hit it with a $5.5 billion lawsuit that alleges the Natick company improperly induced Guidant to violate the terms of its acquisition deal with Johnson &amp; Johnson.
585649
Stocks looked to open slightly higher  on Tuesday, helped by weakening oil prices and news of a  possible merger between Johnson & Johnson JNJ.N and  cardiovascular device maker Guidant Corp. GDT.N.
635340
Shares of CoTherix Inc.  rose 2.7 percent  before the bell on Tuesday after Piper Jaffray initiated coverage of the biopharmaceutical company with an "outperform" rating and a &#36;10 price target.
761615
Credit Suisse First Boston said it was &quot;still cautious&quot; regarding Johnson &amp; Johnson (nyse: JNJ - news - people ) after the company reported quarterly results above Wall Street estimates.
730824
Charges hurt the quarterly results of Johnson & Johnson, Merck & Co. and Schering-Plough Corp., but the drugmakers' shares rose as J&J's earnings beat Wall Street forecasts and Merck sales edged higher despite the withdrawal of its best-selling Vioxx arthritis drug.
667332
U.S. stocks fell on Tuesday as a drop  in oil prices pulled down shares of energy companies and  health-care giant Johnson & Johnson JNJ.N slipped following a  report that it is in negotiations to take over Guidant Corp.  GDT.N.
5729
Health care products giant Johnson &amp; Johnson&#39;s $25.4 billion acquisition of Guidant Corp. could face a tough review from regulators because of their competition in the coronary stent market, analysts say.
470326
Johnson &amp; Johnson said late last night it will acquire Guidant for $23.9 billion, a move that will give the big drug maker a bigger share of the explosive market for heart devices.
350257
Apple Computer Inc. AAPL.O  rose 1.8  percent before the bell on Monday after Bear Stearns raised its  share price target on the company to $72 from $60.